Articles by Jim Miller - Pharmaceutical Executive

ADVERTISEMENT

Articles by Jim Miller

R&D in Transition

The R&D model is in transition and creating new demands on contract services providers.
Jan 17, 2014

If R&D doesn't rebound, the growth prospects of R&D services providers will suffer, and even commercial CMOs will see fewer opportunities coming their way, writes Jim Miller.

The Climate Change in Outsourcing

Ongoing changes create new opportunities for CROs and CMOs.
Jan 2, 2014

Financial, political, and scientific developments that began 10 years ago are only now being felt by the biopharmaceutical contract services industry, writes Jim Miller.

ADVERTISEMENT

Click here